PROTO SCRIPT PHARMACEUTICAL CORP Accounts Receivable, Credit Loss Expense (Reversal)
PROTO SCRIPT PHARMACEUTICAL CORP reported Accounts Receivable, Credit Loss Expense (Reversal) of $8.52 thousand for the 9-month period ending 2017-09-30, per its 10-Q filed 2018-03-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ProvisionForDoubtfulAccounts · last filed 2018-03-08
- PROTO SCRIPT PHARMACEUTICAL CORP accounts receivable, credit loss expense (reversal) for the quarter ending 2017-09-30 was $15.07K.
- PROTO SCRIPT PHARMACEUTICAL CORP accounts receivable, credit loss expense (reversal) for the quarter ending 2017-06-30 was $0.00.
- PROTO SCRIPT PHARMACEUTICAL CORP accounts receivable, credit loss expense (reversal) for the quarter ending 2017-03-31 was -$6.55K.
- PROTO SCRIPT PHARMACEUTICAL CORP accounts receivable, credit loss expense (reversal) for the quarter ending 2016-12-31 was -$19.68K, a 137.85% decline year-over-year.
- PROTO SCRIPT PHARMACEUTICAL CORP accounts receivable, credit loss expense (reversal) for fiscal 2016 was -$19.68K, a 137.85% decline from fiscal 2015.
- PROTO SCRIPT PHARMACEUTICAL CORP accounts receivable, credit loss expense (reversal) for fiscal 2015 was $51.99K.
- PROTO SCRIPT PHARMACEUTICAL CORP accounts receivable, credit loss expense (reversal) for fiscal 2014 was $1.00K.
| Period end | Accounts Receivable, Credit Loss Expense (Reversal) 3 month | Accounts Receivable, Credit Loss Expense (Reversal) 6 month | Accounts Receivable, Credit Loss Expense (Reversal) 9 month | Accounts Receivable, Credit Loss Expense (Reversal) 12 month | Accounts Receivable, Credit Loss Expense (Reversal) 12 month as first filed |
|---|---|---|---|---|---|
| 2017-09-30 | $15.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-08 | $15.07K derived: sum of 2 quarters · filed 2018-03-08 | $8.52K 10-Q · filed 2018-03-08 | -$11.16K derived: sum of 4 quarters · filed 2018-03-08 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-17 | -$6.55K 10-Q · filed 2018-01-17 | -$26.23K derived: sum of 3 quarters · filed 2018-01-17 | -$26.23K derived: sum of 4 quarters · filed 2018-01-17 | |
| 2017-03-31 | -$6.55K 10-Q · filed 2017-11-22 | -$26.23K derived: sum of 2 quarters · filed 2017-11-22 | -$26.23K derived: sum of 3 quarters · filed 2017-11-22 | ||
| 2016-12-31 | -$19.68K derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-10-19 | -$19.68K derived: sum of 2 quarters · filed 2017-10-19 | -$19.68K 10-K/A · filed 2017-10-19 | -$46.72K 10-K · filed 2017-09-20 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-01-06 | $0.00 10-Q · filed 2017-01-06 | |||
| 2016-06-30 | $0.00 10-Q · filed 2016-11-18 | ||||
| 2015-12-31 | $51.99K derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-10-19 | $51.99K derived: sum of 2 quarters · filed 2017-10-19 | $51.99K 10-K/A · filed 2017-10-19 | ||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-01-06 | $0.00 10-Q · filed 2017-01-06 | |||
| 2015-06-30 | $0.00 10-Q · filed 2016-11-18 | ||||
| 2014-05-31 | $1.00K 10-K · filed 2016-05-24 |